Related Experiment Video

Updated: Jul 13, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

The role of VLA4 polymorphisms in multiple sclerosis: an association study

V Andreoli1, R Cittadella, P Valentino

  • 1Institute of Neurological Sciences, National Research Council, Piano Lago di Mangone, Cosenza, Italy. v.andreoli@isn.cnr.it

Journal of Neuroimmunology
|July 5, 2007
PubMed

Insights

Genetic variations in the VLA-4 gene are not linked to multiple sclerosis (MS) risk in the Italian population. This study found no significant association between VLA-4 gene polymorphisms and MS susceptibility.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Inflammatory Diseases

Background:

  • Multiple sclerosis (MS) involves lymphocyte and monocyte infiltration into the central nervous system (CNS), driven by VLA-4 binding to its ligand on brain endothelial cells.
  • Therapeutic antibodies targeting the alpha-4 subunit of VLA-4 have shown efficacy in preventing MS brain lesion development by inhibiting this cell trafficking.

Purpose of the Study:

  • To investigate the potential association between VLA-4 gene polymorphisms and susceptibility to multiple sclerosis (MS).

Main Methods:

  • A case-control study was conducted with 275 MS patients and 255 healthy controls from Italy.
  • Genotyping for VLA-4 gene polymorphisms was performed and compared between the patient and control groups.

Main Results:

  • No statistically significant differences in the frequency of VLA-4 gene polymorphisms were observed between MS patients and controls.
  • The findings indicate a lack of association between the studied VLA-4 polymorphisms and MS risk in the investigated Italian cohort.

Conclusions:

  • VLA-4 gene polymorphisms do not appear to be a significant genetic risk factor for developing multiple sclerosis in the Italian population.
  • Further research may explore other genetic factors or environmental influences contributing to MS susceptibility.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...